Elsevier

Neurobiology of Aging

Volume 32, Issue 2, February 2011, Pages 336-343
Neurobiology of Aging

Cholesterol and serotonin transporter polymorphism interactions in late-life depression

https://doi.org/10.1016/j.neurobiolaging.2009.02.017Get rights and content

Abstract

Background

It has been suggested that the functional polymorphism in the serotonin transporter gene linked promoter region (5-HTTLPR) modifies associations between vascular diseases (coronary artery syndrome or stroke) and depression. This study investigated whether the 5-HTTLPR polymorphism has modifying effects on previously identified associations between cholesterol levels and prevalence/incidence of late-life depression.

Methods

In 732 community residents aged 65+, depression was ascertained (Geriatric Mental State Schedule) at baseline and after 2 years. 5-HTTLPR genotype and lipid levels (total, HDL and LDL cholesterol and triglycerides) were assayed. Covariates were age, sex, education, disability, and cognitive function.

Results

Significant associations between lower baseline HDL cholesterol levels with prevalent and incident depression were also modified by 5-HTTLPR polymorphism, and were only significant in the presence of one or more copies of the s allele.

Conclusion

A more atherogenic lipid profile, as indicated by lower HDL cholesterol is a risk factor for late-life depression and this risk is modified by a gene implicated in serotonin transport.

Introduction

Vascular disease has been suggested to be an important risk factor for depression in late-life (Alexopoulos et al., 1997) and dylipidemia is an important risk factor for vascular outcomes. Low high density lipoprotein (HDL) cholesterol has been found to be a risk factor for incident depression (Kim et al., 2006) as well as a correlate of prevalent depression (Kim et al., 2004, Dimopoulos et al., 2007, Lehto et al., 2008), consistent with this hypothesis. However, for total cholesterol, lower rather than higher levels have more often been found to be associated with depression in older people (Aijänseppä et al., 2002, Morgan et al., 1993). One plausible underlying mechanism is that a reduction in serum cholesterol might decrease brain cell membrane cholesterol, and decrease the exposure of protein serotonin receptors on the membrane surface, resulting in a poorer uptake of serotonin from the blood and less serotonin entry into brain cells (Engelberg, 1992). Indeed, serum cholesterol levels have been found to be positively associated with serotonergic activity measured by cortisol responses to meta-chlorophenylpiperazine (Buydens-Branchey et al., 2000, Terao et al., 2000), although this finding has not always been replicated (Papakostas et al., 2003, Sarchiapone et al., 2001).

The serotonin transporter (5-HTT) of the brain provides the primary target for the action of selective antidepressant drugs, and is a plausible candidate gene for mediating susceptibility to depression (Ogilvie et al., 1996). There is a biallelic polymorphism in the 5-HTT gene linked promoter region (5-HTTLPR) with short (s) and long (l) alleles. In relation to cholesterol levels, total cholesterol levels have been found to be significantly higher in s/l heterozygotes than either s/s or l/l homozygotes (Comings et al., 1999), and low density lipoprotein (LDL) cholesterol levels have been found to be significantly higher in those with l allele than those with s allele (Fischer et al., 2006). Despite the potential for interactive effects between 5-HTTLPR polymorphism and cholesterol levels on depression, this has not been investigated to date in a community population.

In a previous analysis of data from a prospective community study of an older Korean population, we found that cholesterol levels were associated with prevalence and incidence of depression (Kim et al., 2004, Kim et al., 2006); specifically, lower baseline high density lipoprotein (HDL) cholesterol levels was associated with both prevalent and incident depression, and a U-shaped association was found between baseline total cholesterol and incident depression. In the present analyses, we aimed to investigate whether cholesterol levels (total and sub-fractions) were associated with 5-HTTLPR polymorphism, and whether the 5-HTTLPR polymorphism modified previously identified associations between baseline levels and incidence of depression.

Section snippets

Study outline and participants

An analysis was carried out on data from a prospective community survey of late-life psychiatric morbidity carried out in Kwangju, South Korea from 2001 to 2003, in collaboration with the 10/66 International Dementia Research Program in Developing Countries (Prince et al., 2003). The purpose of the baseline study was to investigate the prevalence and correlates of late-life depression and dementia in this population, particularly focusing on the role of specific somatic disorders and blood

Results

Of the 1204 participants at the first interview at baseline, 732 (61%) participated in the second more intensive examination. Participants at both interviews were less educated than those only present at the first (mean (S.D.) years of education 3.4 (4.2) and 4.0 (4.4), respectively; p = 0.035), and had lower cognitive function (mean (S.D.) scores on MMSE 23.3 (5.0) and 24.3 (5.1), respectively; p = 0.002). However, no significant differences were observed between the participants and

Discussion

In this prospective study of an older community population, the associations between lower baseline HDL cholesterol levels and both prevalent and incident depression were modified by 5-HTTLPR genotype, and were significant in the presence of one or more copies of the s allele. Associations between total cholesterol levels and depression were not significantly modified by 5-HTTLPR genotype. These results suggest that the s allele may confer vulnerability for depression in the presence of lower

Conflicts of interest statement

The authors declare no conflicts of interest.

Acknowledgements

This research was supported by a grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A050047 and A050113).

References (43)

  • D. Nakatani et al.

    Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction

    Am. Heart J.

    (2005)
  • A.D. Ogilvie et al.

    Polymorphism in serotonin transporter gene associated with susceptibility to major depression

    Lancet

    (1996)
  • G.I. Papakostas et al.

    Serum cholesterol and serotonergic function in major depressive disorder

    Psychiatry Res.

    (2003)
  • M. Prince et al.

    Dementia diagnosis in developing countries: a cross-cultural validation study

    Lancet

    (2003)
  • M. Sarchiapone et al.

    Cholesterol and serotonin indices in depressed and suicidal patients

    J. Affect. Disord.

    (2001)
  • T. Terao et al.

    Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women

    Psychiatry Res.

    (2000)
  • S. Aijänseppä et al.

    Serum cholesterol and depressive symptoms in elderly Finnish men

    Int. J. Geriatr. Psychiatry

    (2002)
  • G.S. Alexopoulos et al.

    ‘Vascular depression’ hypothesis

    Arch. Gen. Psychiatry

    (1997)
  • R. Chen et al.

    A community-based study of depression in older people in Hefei, China—the GMS-AGECAT prevalence, case validation and socio-economic correlates

    Int. J. Geriatr. Psychiatry

    (2004)
  • M.Y. Chong et al.

    Community study of depression in Taiwan: prevalence, life events and socio-demographic correlates

    Br. J. Psychiatry

    (2001)
  • J.R.M. Copeland et al.

    A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT

    Psychol. Med.

    (1986)
  • Cited by (26)

    • Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders

      2015, Journal of Affective Disorders
      Citation Excerpt :

      More recently, the serotonergic system, widely established as being linked to suicidality (Arango et al., 1995; Jokinen et al., 2009; Traskman et al., 1981), has been studied in the area of genetics and presented interesting results. For example, the presence of sequence variants in HTR5A (serotonin type 5A receptor gene) was strongly associated with high plasma levels of triglycerides (Zhang et al., 2010) and associations between lower HDL cholesterol levels with depression were also modified by a 5-HTTLPR (serotonin transporter gene linked promoter region) polymorphism; however this association was only significant in the presence of one or more copies of the s (short) allele (Kim et al., 2011). Some studies have suggested that lower cholesterol can be more linked to violent suicide attempts than suicidality itself [e.g. (Atmaca et al., 2008)].

    • Subchronic and mild social defeat stress accelerates food intake and body weight gain with polydipsia-like features in mice

      2014, Behavioural Brain Research
      Citation Excerpt :

      In humans, there have been reports that low levels of T-CHO and HDL-C in serum may be good biomarkers for suicidal risk and major depression [55–57]. In addition, Kim et al. [58] reported that lower HDL-C is a risk factor for late-life depression and that this risk is modified by a gene implicated in serotonin transport in humans. Our sCSDS mouse model might shares features such as cholesterol and serotonin metabolism with psychiatric disorders.

    View all citing articles on Scopus
    View full text